44 Wallentine PPTs View free & download

Computing and Information Sciences Dr' Virgil Wallentine http:www'cis'ksu'edu - Computing and Information Sciences Dr' Virgil Wallentine http:www'cis'ksu'edu

Computing and Information Sciences Dr' Virgil Wallentine http:www'cis'ksu'edu

| PowerPoint PPT presentation | free to view

Model Checking Software Artifacts PowerPoint PPT Presentation

Model Checking Software Artifacts - Todd Wallentine. http://www.cis.ksu.edu/bandera. http://www.cis. ... Informal : English and examples. Intentionally under-specified to allow implementor freedom ...

Todd Wallentine. http://www.cis.ksu.edu/bandera. http://www.cis. ... Informal : English and examples. Intentionally under-specified to allow implementor freedom ...

| PowerPoint PPT presentation | free to download

Comparative Study of Techniques for Parallelization of the Grid Simulation Problem PowerPoint PPT Presentation

Comparative Study of Techniques for Parallelization of the Grid Simulation Problem - Comparative Study of Techniques for Parallelization of the Grid Simulation Problem Prepared by Arthi Ramachandran Kansas State University

Comparative Study of Techniques for Parallelization of the Grid Simulation Problem Prepared by Arthi Ramachandran Kansas State University

| PowerPoint PPT presentation | free to download

Robot Route Planning using Cellular Automata PowerPoint PPT Presentation

Robot Route Planning using Cellular Automata - The Route-Planner has a thread pool. ... Each cell polls this NextStep-Grid to retrieve the routing decisions made by the Route-Planner. ...

The Route-Planner has a thread pool. ... Each cell polls this NextStep-Grid to retrieve the routing decisions made by the Route-Planner. ...

| PowerPoint PPT presentation | free to download

Fermentation Extract and Toxic Plant Effect on The Physiology of Rumen Microorganisms PowerPoint PPT Presentation

Fermentation Extract and Toxic Plant Effect on The Physiology of Rumen Microorganisms - AL 757 Special Topics in Rumen Microbiology LEC 15 Rumen Fermentation by Fungi (Mould & Yeast) Lab. of Rumen Microbiology and Biotechnology, GSNU, Korea.

AL 757 Special Topics in Rumen Microbiology LEC 15 Rumen Fermentation by Fungi (Mould & Yeast) Lab. of Rumen Microbiology and Biotechnology, GSNU, Korea.

| PowerPoint PPT presentation | free to view

Graphical User Interface and Job Distribution Optimizer for a Virtual Pipeline Simulation Testbed PowerPoint PPT Presentation

Graphical User Interface and Job Distribution Optimizer for a Virtual Pipeline Simulation Testbed - Design a GUI to create and manipulate the pipeline system. ... Components: Pipes, split, station, driver, compressor, orifice... Draw, Edit, Delete, Move ...

Design a GUI to create and manipulate the pipeline system. ... Components: Pipes, split, station, driver, compressor, orifice... Draw, Edit, Delete, Move ...

| PowerPoint PPT presentation | free to download

Robot Route Planning using Cellular Automata - Such a system which is fully automated is called ... if MFj = false. add j to TODO list and set MFj = true. previous_cellj = i. Route Planner Algorithm ...

Such a system which is fully automated is called ... if MFj = false. add j to TODO list and set MFj = true. previous_cellj = i. Route Planner Algorithm ...

| PowerPoint PPT presentation | free to view

Ticagrelor compared with clopidogrel in patients with acute coronary syndromes the PLATelet Inhibition and patient Outcomes trial PowerPoint PPT Presentation

Ticagrelor compared with clopidogrel in patients with acute coronary syndromes the PLATelet Inhibition and patient Outcomes trial - STEMI Ticagrelor compared with clopidogrel in patients with acute coronary syndromes the PLATelet Inhibition and patient Outcomes trial Outcomes in patients with ...

STEMI Ticagrelor compared with clopidogrel in patients with acute coronary syndromes the PLATelet Inhibition and patient Outcomes trial Outcomes in patients with ...

| PowerPoint PPT presentation | free to download

UPDATE%20ON%20ANTIPLATELET%20THERAPY%20IN%20THE%20TREATMENT%20AND%20PREVENTION%20OF%20CARDIOVASCULAR%20DISEASE PowerPoint PPT Presentation

UPDATE%20ON%20ANTIPLATELET%20THERAPY%20IN%20THE%20TREATMENT%20AND%20PREVENTION%20OF%20CARDIOVASCULAR%20DISEASE - ... placebo-controlled trials show that both PPIs and histamine-2 receptor antagonists decrease the development of endoscopic ulcers in low-dose aspirin ... CABG ...

... placebo-controlled trials show that both PPIs and histamine-2 receptor antagonists decrease the development of endoscopic ulcers in low-dose aspirin ... CABG ...

| PowerPoint PPT presentation | free to download

ATRIAL FIBRILLATION AND STROKE PowerPoint PPT Presentation

ATRIAL FIBRILLATION AND STROKE - atrial fibrillation and stroke why should we care?

atrial fibrillation and stroke why should we care?

| PowerPoint PPT presentation | free to view

Ticagrelor versus clopidogrel in patients with acute coronary syndromes undergoing coronary artery bypass surgery: results from the PLATO trial - CABG Ticagrelor versus clopidogrel in patients with acute coronary syndromes undergoing coronary artery bypass surgery: results from the PLATO trial

CABG Ticagrelor versus clopidogrel in patients with acute coronary syndromes undergoing coronary artery bypass surgery: results from the PLATO trial

| PowerPoint PPT presentation | free to download

Evaluating the Effectiveness of Slicing for Model Reduction of Concurrent ObjectOriented Programs PowerPoint PPT Presentation

Evaluating the Effectiveness of Slicing for Model Reduction of Concurrent ObjectOriented Programs - Evaluating the Effectiveness of. Slicing for Model Reduction of ... US Air Force Office of Scientific Research. US National Science Foundation ...

Evaluating the Effectiveness of. Slicing for Model Reduction of ... US Air Force Office of Scientific Research. US National Science Foundation ...

| PowerPoint PPT presentation | free to view

Proposed revision of air passenger rights PowerPoint PPT Presentation

Proposed revision of air passenger rights - Simplification of complaint-handling and coordination of enforcement * Deadlines for all Out-of-court complaint handling bodies Enhanced coordination and exchange ...

Simplification of complaint-handling and coordination of enforcement * Deadlines for all Out-of-court complaint handling bodies Enhanced coordination and exchange ...

| PowerPoint PPT presentation | free to download

Drug Eluting VS Bare Metal Stents - Drug Eluting VS Bare Metal Stents

Drug Eluting VS Bare Metal Stents

| PowerPoint PPT presentation | free to view

Managing the acute coronary syndrome: What is new? PowerPoint PPT Presentation

Managing the acute coronary syndrome: What is new? - PCI? 88% of patients believed ... Antiplatelet Therapy Aspirin 300mg Clopidogrel 600mg Abciximab Impact of door to balloon time ACC-NCDR Cath PCI Registry: 2005 ...

PCI? 88% of patients believed ... Antiplatelet Therapy Aspirin 300mg Clopidogrel 600mg Abciximab Impact of door to balloon time ACC-NCDR Cath PCI Registry: 2005 ...

| PowerPoint PPT presentation | free to view

TAO : Treatment of Acute Coronary Syndromes with Otamixaban PowerPoint PPT Presentation

TAO : Treatment of Acute Coronary Syndromes with Otamixaban - ... 787-795 Extrinsic pathway Tissue factor, FVII Thrombin (F IIa) Fibrin Formation Platelet Aggregation Intrinsic pathway FXII, FXI, FIX, FVIII, PL, ...

... 787-795 Extrinsic pathway Tissue factor, FVII Thrombin (F IIa) Fibrin Formation Platelet Aggregation Intrinsic pathway FXII, FXI, FIX, FVIII, PL, ...

| PowerPoint PPT presentation | free to download

The Meaning and Scope of the Acte Clair Doctrine in the ECJ PowerPoint PPT Presentation

The Meaning and Scope of the Acte Clair Doctrine in the ECJ - The Meaning and Scope of the Acte Clair Doctrine in ... Y.Rocher. 1/04. Comm/SW CG. 02. 8/7 Exit. 4/5. Ref 21. 3/2. Tauson. 29/6. not135. C-101/05. C-101/05. ...

The Meaning and Scope of the Acte Clair Doctrine in ... Y.Rocher. 1/04. Comm/SW CG. 02. 8/7 Exit. 4/5. Ref 21. 3/2. Tauson. 29/6. not135. C-101/05. C-101/05. ...

| PowerPoint PPT presentation | free to download

Fredric Ginsberg, MD PowerPoint PPT Presentation

Fredric Ginsberg, MD - Frequently, shock develops after presentation for myocardial infarction. - SHOCK Registry ... STEMI = ST-segment Elevation Myocardial Infarction ...

Frequently, shock develops after presentation for myocardial infarction. - SHOCK Registry ... STEMI = ST-segment Elevation Myocardial Infarction ...

| PowerPoint PPT presentation | free to view

Up-to-date : Antiplatelet Therapy for Acute Coronary Syndrome PowerPoint PPT Presentation

Up-to-date : Antiplatelet Therapy for Acute Coronary Syndrome - Acute Coronary Syndrome and ER Management Increasing CV Mortality Top Ten Causes of Death in Thailand CAD: 2 Major Presentations Stable angina Unstable angina / ACS ...

Acute Coronary Syndrome and ER Management Increasing CV Mortality Top Ten Causes of Death in Thailand CAD: 2 Major Presentations Stable angina Unstable angina / ACS ...

| PowerPoint PPT presentation | free to view

Quand et pourquoi remplacer une anti-vitamine K par un nouvel anticoagulant ? PowerPoint PPT Presentation

Quand et pourquoi remplacer une anti-vitamine K par un nouvel anticoagulant ? - Title: Quand et pourquoi remplacer une anti-vitamine K par un nouvel anticoagulant ? Author: Utilisateur Windows Last modified by: telnet Created Date

Title: Quand et pourquoi remplacer une anti-vitamine K par un nouvel anticoagulant ? Author: Utilisateur Windows Last modified by: telnet Created Date

| PowerPoint PPT presentation | free to download

Controversies in Cardiology: Stable CAD PowerPoint PPT Presentation

Controversies in Cardiology: Stable CAD - Disclosure: Dr. Boden receives research grants, speakers' bureau honoraria, or ... Med Management (MM), Percutaneous Coronary Intervention (PCI), Coronary Artery ...

Disclosure: Dr. Boden receives research grants, speakers' bureau honoraria, or ... Med Management (MM), Percutaneous Coronary Intervention (PCI), Coronary Artery ...

| PowerPoint PPT presentation | free to view

Nature management and Data management PowerPoint PPT Presentation

Nature management and Data management - scenic beauty. state financed. additional social and economic purposes. embedded in the region ... to facilitate the effective use also for non-experts ...

scenic beauty. state financed. additional social and economic purposes. embedded in the region ... to facilitate the effective use also for non-experts ...

| PowerPoint PPT presentation | free to view

Les Syndromes Coronariens Aigus : diagnostic, mise au point, therapeutique PowerPoint PPT Presentation

Les Syndromes Coronariens Aigus : diagnostic, mise au point, therapeutique - Non-specific ECG changes and even normal ECG. Patients with a presumed STEMI ... GUSTO IIb indicates: RR reduction: 22% at 72h. RR reduction: 17% at 7days ...

Non-specific ECG changes and even normal ECG. Patients with a presumed STEMI ... GUSTO IIb indicates: RR reduction: 22% at 72h. RR reduction: 17% at 7days ...

| PowerPoint PPT presentation | free to view

ACCAHA Guidelines for the Management of Patients with Unstable Angina and NonSTSegment Elevation MI PowerPoint PPT Presentation

ACCAHA Guidelines for the Management of Patients with Unstable Angina and NonSTSegment Elevation MI - 5,315,000 Americans visited Emergency Departments for chest pain in 1997 ... ST-T 's, chest pain, markers. Initial Chest Pain. Evaluation. Symptoms Suggestive of ACS ...

5,315,000 Americans visited Emergency Departments for chest pain in 1997 ... ST-T 's, chest pain, markers. Initial Chest Pain. Evaluation. Symptoms Suggestive of ACS ...

| PowerPoint PPT presentation | free to view

Jacques Genest, Jr', MD FRCPC FACC - Jacques Genest, Jr', MD FRCPC FACC

Jacques Genest, Jr', MD FRCPC FACC

| PowerPoint PPT presentation | free to view

Proceso - Presence of a critical stenosis in left ... Turi ZG, Doshi SK, Sievert H, Buchbinder M, Mullin CM, Sick P. Percutaneous closure of the left atrial appendage ...

Presence of a critical stenosis in left ... Turi ZG, Doshi SK, Sievert H, Buchbinder M, Mullin CM, Sick P. Percutaneous closure of the left atrial appendage ...

| PowerPoint PPT presentation | free to download

Acute Coronary Syndromes PowerPoint PPT Presentation

Acute Coronary Syndromes - Pathophysiology. Clinical Presentation and Diagnostic Triad ... Approximately 1 million Americans will have a. new/recurrent myocardial infarction this year ...

Pathophysiology. Clinical Presentation and Diagnostic Triad ... Approximately 1 million Americans will have a. new/recurrent myocardial infarction this year ...

| PowerPoint PPT presentation | free to view

Dott. Antonio Butera PowerPoint PPT Presentation

Dott. Antonio Butera - U. O. CARDIOLOGIA con UTIC Lamezia Terme Preparazione farmacologica alla PTCA: STEMI Negli ospedali senza emodinamica Dott. Antonio Butera Lamezia Terme

U. O. CARDIOLOGIA con UTIC Lamezia Terme Preparazione farmacologica alla PTCA: STEMI Negli ospedali senza emodinamica Dott. Antonio Butera Lamezia Terme

| PowerPoint PPT presentation | free to view

Percutaneous Coronary Interventions in ACS without ST Elevation PowerPoint PPT Presentation

Percutaneous Coronary Interventions in ACS without ST Elevation - ICTUS Trial. Presented at ESC 2004 ... ICTUS Trial ... managed by a selective invasive strategy (ICTUS data) if co-morbidities and/or ...

ICTUS Trial. Presented at ESC 2004 ... ICTUS Trial ... managed by a selective invasive strategy (ICTUS data) if co-morbidities and/or ...

| PowerPoint PPT presentation | free to view

Mercury User Group Meeting PowerPoint PPT Presentation

Mercury User Group Meeting - ... Defects Tests Test instances Test sets Requirements QuickTest Professional 9.0 New Environment Support Web services Macromedia Flex Utilizing QTP ...

... Defects Tests Test instances Test sets Requirements QuickTest Professional 9.0 New Environment Support Web services Macromedia Flex Utilizing QTP ...

| PowerPoint PPT presentation | free to view

ASSENT 3 Plus PowerPoint PPT Presentation

ASSENT 3 Plus - Primary Efficacy plus Safety - 30 day Death or In-hospital MI, Refractory ... Pre-hospital TNK plus heparin does, however, appear to be safe and lower treatment times ...

Primary Efficacy plus Safety - 30 day Death or In-hospital MI, Refractory ... Pre-hospital TNK plus heparin does, however, appear to be safe and lower treatment times ...

| PowerPoint PPT presentation | free to view

Antiplatelet Drug Resistance in Coronary Artery Disease: PowerPoint PPT Presentation

Antiplatelet Drug Resistance in Coronary Artery Disease: - Director of Cardiovascular Research. Assistant Professor of Medicine ... (PRI 50%) received additional 600mg bolus (max 2400 mg) until reaching therapeutic target. ...

Director of Cardiovascular Research. Assistant Professor of Medicine ... (PRI 50%) received additional 600mg bolus (max 2400 mg) until reaching therapeutic target. ...

| PowerPoint PPT presentation | free to view

ACS is a major public health challenge PowerPoint PPT Presentation

ACS is a major public health challenge - ACS is a major public health challenge In the US: Over 1.5 million people experience ACS annually1 In the EU: ACS is the most common cause of death, accounting for ...

ACS is a major public health challenge In the US: Over 1.5 million people experience ACS annually1 In the EU: ACS is the most common cause of death, accounting for ...

| PowerPoint PPT presentation | free to view

Mortality trends in cardiovascular disease in schizophrenia in Sweden PowerPoint PPT Presentation

Mortality trends in cardiovascular disease in schizophrenia in Sweden - Mortality trends in cardiovascular disease in schizophrenia ... Atheroma. Fibrous. Plaque. Complicated. Lesion/Rupture. Endothelial dysfunction. Smooth muscle ...

Mortality trends in cardiovascular disease in schizophrenia ... Atheroma. Fibrous. Plaque. Complicated. Lesion/Rupture. Endothelial dysfunction. Smooth muscle ...

| PowerPoint PPT presentation | free to view

Prehospital Thrombolysis PowerPoint PPT Presentation

Prehospital Thrombolysis - Review of evidence relating time of reperfusion treatment to outcome ... is associated with a fourfold increase of aborted myocardial infarction ...

Review of evidence relating time of reperfusion treatment to outcome ... is associated with a fourfold increase of aborted myocardial infarction ...

| PowerPoint PPT presentation | free to view

Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering – MIRACL: Rationale and Results PowerPoint PPT Presentation

Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering – MIRACL: Rationale and Results - Despite modern advances in the management of acute coronary syndromes, the relative risk of death or nonfatal MI can be higher over the first year, ...

Despite modern advances in the management of acute coronary syndromes, the relative risk of death or nonfatal MI can be higher over the first year, ...

| PowerPoint PPT presentation | free to view

Angioplasty of the culprit lesion has been proven to be of value: PowerPoint PPT Presentation

Angioplasty of the culprit lesion has been proven to be of value: - ST elevation MI compared to thrombolytics Reduces mortality and strokes (and ... What is the Basis of the Cardiology Community's Preoccupation with PCI? ...

ST elevation MI compared to thrombolytics Reduces mortality and strokes (and ... What is the Basis of the Cardiology Community's Preoccupation with PCI? ...

| PowerPoint PPT presentation | free to view

Air Passengers Rights PowerPoint PPT Presentation

Air Passengers Rights - C-402/07, Sturgeon v Condor, reference for a preliminary ruling of the ... C-525/08 Bienek v Condor. Reference from the Bundesgerichtshof asking ...

C-402/07, Sturgeon v Condor, reference for a preliminary ruling of the ... C-525/08 Bienek v Condor. Reference from the Bundesgerichtshof asking ...

| PowerPoint PPT presentation | free to view

BIOMARCADORES EN EL SCASEST. ESTRATIFICACIУN DEL RIESGO. ANTIAGREGANTES. PowerPoint PPT Presentation

BIOMARCADORES EN EL SCASEST. ESTRATIFICACIУN DEL RIESGO. ANTIAGREGANTES. - BIOMARCADORES EN EL SCASEST. ESTRATIFICACI N DEL RIESGO. ANTIAGREGANTES. Dr. Antonio Padilla. Servicio de Medicina Intensiva. Hospital La Mancha Centro.

BIOMARCADORES EN EL SCASEST. ESTRATIFICACI N DEL RIESGO. ANTIAGREGANTES. Dr. Antonio Padilla. Servicio de Medicina Intensiva. Hospital La Mancha Centro.

| PowerPoint PPT presentation | free to download

With or without constraints An empirical comparison of two approaches to estimate interaction effect PowerPoint PPT Presentation

With or without constraints An empirical comparison of two approaches to estimate interaction effect - With or without constraints? An empirical comparison of ... Many social psychological models postulate interaction effects ... The additive effects differed. ...

With or without constraints? An empirical comparison of ... Many social psychological models postulate interaction effects ... The additive effects differed. ...

| PowerPoint PPT presentation | free to view

Dutch pending cases C47004 Van Dijk: and case C804 Bujura: PowerPoint PPT Presentation

Dutch pending cases C47004 Van Dijk: and case C804 Bujura: - ... from outset that he will pursue economic activity in UK ... A-G Maduro Marks & Spencer: transnational situation. A-G L ger Van Hilten: no access to Art. ...

... from outset that he will pursue economic activity in UK ... A-G Maduro Marks & Spencer: transnational situation. A-G L ger Van Hilten: no access to Art. ...

| PowerPoint PPT presentation | free to view

ESTEEM: Efficacy and safety of the oral direct thrombin inhibitor ximelagatran in patients with rece PowerPoint PPT Presentation

ESTEEM: Efficacy and safety of the oral direct thrombin inhibitor ximelagatran in patients with rece - ESTEEM: Efficacy and safety of the oral direct thrombin inhibitor ximelagatran ... Wallentin L, Wilcox RG, Weaver WD et al. for the ESTEEM Investigators. ...

ESTEEM: Efficacy and safety of the oral direct thrombin inhibitor ximelagatran ... Wallentin L, Wilcox RG, Weaver WD et al. for the ESTEEM Investigators. ...

| PowerPoint PPT presentation | free to view

Overview of Atherothrombotic Therapy: Secondary Prevention PowerPoint PPT Presentation

Overview of Atherothrombotic Therapy: Secondary Prevention - HMG-CoA reductase inhibitor for LDL-C 130 mg/dL ... Sparrow, et al. 1978. 0.76 (0.37-1.58) Vlietstra, et al. 1986. 0.63 (0.51-0.78) ...

HMG-CoA reductase inhibitor for LDL-C 130 mg/dL ... Sparrow, et al. 1978. 0.76 (0.37-1.58) Vlietstra, et al. 1986. 0.63 (0.51-0.78) ...

| PowerPoint PPT presentation | free to view

Tax Treatment of Pensions in Finland PowerPoint PPT Presentation

Tax Treatment of Pensions in Finland - 35 % withholding tax on gross amount - tax treaties - public sector pensions: 35 % tax almost always ... Finnish source public sector pension is her only income ...

35 % withholding tax on gross amount - tax treaties - public sector pensions: 35 % tax almost always ... Finnish source public sector pension is her only income ...

| PowerPoint PPT presentation | free to view

Wallentine PowerPoint PPT Presentations